AGBL Egypt is selected as the main supplier and operator of technology for the Egyptian Genome Project

Egypt has announced its plans to establish a map of the Egyptian human genome and enter the world of precision medicine, the Egyptian President Abdel Fattah El Sisi has been briefed on the development of the project by Prime Minister Mustafa Mabdouli and Minister of Higher Education Khaled Abdel Ghaffar.

Egypt Today website reported that “The project could help Egypt enter the era of precision medicine, gene therapy, and future specialized drugs based on genetic combinations, according to a statement from the Egyptian Presidency Spokesperson Bassam Radi”.

AGBL Egypt has been selected by the project as the main supplier of technology, under its roles AGBL Egypt will provide support and service for the project per the signed contract with the Egyptian Center for Research and Regenerative Medicine, which will be entrusted to run the project.

Mr Mohamed Abdel Hakim, the Regional Sales Director at AGBL Group commented on the news by saying: “We take great pride in being part of the “Egyptian Genome Project” family, we believe that our expertise with similar large scale products for Population Genomics in the region will enable us to provide the necessary support to this ambitious project”.

Please read the Press Release http://bit.ly/2NtMBTL

 

 

About AGBL Egypt

AGBL Egypt is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets. AGBL Egypt is headquartered in Cairo and covers Egypt and Sudan.

 

2021-03-18T12:48:49+00:00 March 17th, 2021|Categories: News|0 Comments